Australia markets closed

AbCellera Biologics Inc. (8QQ.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
3.4030+0.0520 (+1.55%)
At close: 03:44PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
35,787
38,025
485,424
375,203
233,155
Cost of revenue
-
0
66,436
45,516
27,143
Gross profit
-
38,025
418,988
329,687
206,012
Operating expenses
Research development
162,298
175,658
107,879
62,062
29,393
Selling general and administrative
76,991
75,179
66,755
48,761
15,752
Total operating expenses
248,958
261,077
191,923
107,788
41,661
Operating income or loss
-213,171
-223,052
227,065
221,899
164,351
Interest expense
-
-
4,045
5,225
6,511
Total other income/expenses net
1,654
6,776
-4,045
-6,080
-300
Income before tax
-168,628
-174,029
239,099
219,149
157,833
Income tax expense
-21,730
-27,631
80,580
65,685
38,915
Income from continuing operations
-146,898
-146,398
158,519
153,464
118,918
Net income
-146,898
-146,398
158,519
153,464
118,918
Net income available to common shareholders
-146,898
-146,398
158,519
153,464
85,101
Basic EPS
-0.44
-0.51
0.56
0.56
0.53
Diluted EPS
-0.44
-0.51
0.50
0.48
0.45
Basic average shares
288,140
289,166
285,057
275,764
159,195
Diluted average shares
295,752
289,166
314,827
318,294
263,130